RevaTis
Didier Serteyn is the CEO at Revatis. Didier graduated doctor of veterinary medicine from the University of Liège in 1982 and obtained his PhD degree in 1989.
This person is not in any offices
RevaTis
RevaTis and the University of Liège have developed and patented a specific procedure for the collection, production, and storage of autologous muscle-derived mesenchymal stem cells (MdMSC) for immediate therapeutic use or storage for further processing. RevaTis technology is minimally invasive and offers benefits for generating a large number of autologous stem cells.